StonvexLoading…
StonvexStonvexStonvexCore line items from AQB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $2.47M | $3.14M | $1.17M | $127.66K |
Operating Income | $-13.67M | $-22.32M | $-22.12M | $-16.25M |
Net Income | $-27.56M | $-22.16M | $-22.32M | $-16.40M |
EPS (Diluted) | $-7.17 | $-5.78 | $-0.32 | Not available |
Total Assets | $187.55M | $213.84M | $228.44M | $125.78M |
Total Liabilities | $22.53M | $21.92M | $14.63M | $10.90M |
Cash & Equivalents | $8.20M | $101.64M | $88.45M | $95.75M |
Free Cash Flow OCF − CapEx | $-93.13M | $-88.48M | $-26.19M | $-18.26M |
Shares Outstanding | 3.85M | 3.83M | 71.03M | 55.50M |